인쇄하기
취소

New drug R&D investment by conglomerates near to reap.

Published: 2001-06-25 07:00:00
Updated: 2001-06-25 07:00:00
Many conglomerates who entered into the pharmaceutical business seem to harvest soon their investment for an R&D of new drug discovery.

LG, SK and Cheiljedang already committed their technology exports of new drugs to foreign multinational drug corporations, and now, Kolon announced on June 19 that an anti-arthritis drug was successfully developed by the bio-engineering technology.

They p...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.